Search Results - "DIRINCK, EVELINE L."

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity by Van Herck, Mikhaïl A, Weyler, Jonas, Kwanten, Wilhelmus J, Dirinck, Eveline L, De Winter, Benedicte Y, Francque, Sven M, Vonghia, Luisa

“…Non-alcoholic fatty liver disease (NAFLD) constitutes a spectrum of disease states characterized by hepatic steatosis and is closely associated to obesity and…”
Get full text

751-P: Effect Of Once-Weekly Semaglutide on Weight Change and Metabolic Control in People with Type 1 Diabetes—Six-Months Results from the Real-World STEMT Trial by MERTENS, JONATHAN, DE WINTER, HENNAH T., MAZLOM, HADI, PEIFFER, FRIDA W., DIRINCK, EVELINE L., BOCHANEN, NIELS, VAN GAAL, LUC F., DE BLOCK, CHRISTOPHE

“…Introduction: the SUSTAIN trials have shown significant improvements in weight and HbA1c levels in people with type 2 diabetes, but the effect and safety of…”
Get full text

Exposure to Persistent Organic Pollutants: Relationship With Abnormal Glucose Metabolism and Visceral Adiposity by DIRINCK, Eveline L, DIRTU, Alin C, GOVINDAN, Malarvannan, COVACI, Adrian, VAN GAAL, Luc F, JORENS, Philippe G

“…The contribution of persistent organic pollutants (POPs) to the pandemic of type 2 diabetes mellitus and obesity has been assumed but remains speculative. Our…”
Get full text

646-P: Sustained Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring in Adults with Type 1Diabetes: 24-Month Results of the ALERTT1 Trial by VISSER, MARGARETHA M., CHARLEER, SARA, FIEUWS, STEFFEN, DE BLOCK, CHRISTOPHE, HILBRANDS, ROBERT, VAN HUFFEL, LIESBETH, MAES, TOON, VANHAVERBEKE, GERD, DIRINCK, EVELINE L., MYNGHEER, NELE, VERCAMMEN, CHRIS F., NOBELS, FRANK, KEYMEULEN, BART, MATHIEU, CHANTAL, GILLARD, PIETER

“…Background: The 6-month multicenter randomized controlled ALERTT1 trial showed improvement of time in range (TIR; 70-180 mg/dL) , HbA1c, time <54 mg/dL and…”
Get full text

726-P: Glucose Control Using Fast-Acting Insulin Aspart in a Real-World Setting: A One-Year Multicenter Study in People with Type 1 Diabetes Using Continuous Glucose Monitoring by BILLION, LISA, CHARLEER, SARA, VERBRAEKEN, LAURENS, STERCKX, MIRA, VANGELABBEEK, KATO, DE BLOCK, NATHALIE, JANSSEN, CHARLIEN, BOLSENS, NANCY, DIRINCK, EVELINE L., PEIFFER, FRIDA W., VAN DESSEL, KRISTOF P., MATHIEU, CHANTAL, GILLARD, PIETER, DE BLOCK, CHRISTOPHE

“…Objective: Data on switching from traditional mealtime insulin analogs to fast-acting insulin aspart (Fiasp) in routine clinical practice are sparse. The aim…”
Get full text

Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish by Dirinck, Eveline L, Dirtu, Alin C, Govindan, Malarvannan, Covaci, Adrian, Jorens, Philippe G, Van Gaal, Luc F

“…A subset of obese individuals does not exhibit metabolically unfavorable features; this group is referred to as metabolically healthy obese (MHO). Serum…”
Get full text

Clinical Importance of One-Hour Plasma Glucose in Relation to Diabetes and Metabolic Syndrome in an Obese Population by HAVERALS, LIEN, VAN DESSEL, KRISTOF P.S., VERRIJKEN, AN, DIRINCK, EVELINE L., PEIFFER, FRIDA W., GAAL, LUC VAN, BLOCK, CHRISTOPHE DE

“…Introduction: Type 2 diabetes mellitus (T2DM) is increasingly prevalent and associated with increased morbi/mortality. In Caucasian obese subjects we…”
Get full text

Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish12 by Dirinck, Eveline L, Dirtu, Alin C, Govindan, Malarvannan, Covaci, Adrian, Jorens, Philippe G, Van Gaal, Luc F

“…Background: A subset of obese individuals does not exhibit metabolically unfavorable features; this group is referred to as metabolically healthy obese (MHO)…”
Get full text